Ezetimibe: an update on its clinical usefulness in specific patient groups

D Hammersley, M Signy - Therapeutic advances in chronic …, 2017 - journals.sagepub.com
The aim of pharmacological lipid modification is to reduce low-density lipoprotein
cholesterol (LDL-C) as a means of either secondary or primary prevention of cardiovascular …

Role of non-invasive imaging in the management of coronary artery disease: an assessment of likely change over the next 10 years. A report from the British …

…, S Neubauer, DJ Pennell, M Rothman, M Signy… - Heart, 2007 - heart.bmj.com
Coronary angiography has been the gold standard for determining the severity, extent and
prognosis of coronary atheromatous disease for the past 15–20 years. However, established …

Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection

P Muir, AJ Tilzey, TAH English, F Nicholson, M Signy… - The Lancet, 1989 - Elsevier
By means of two different IgM-capture assays, enterovirus-specific IgM responses were
shown in 9 of 14 (64%) patients with chronic relapsing pericarditis. This finding suggests …

Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris

…, J Coltart, M Griffith, MB Maltz, M Signy - The American Journal of …, 1989 - Elsevier
In a double-blind parallel group study, 46 patients with chronic stable angina were
randomized, after a 2-week placebo washout period, to 1 of 3 treatment groups for an …

Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era

D Hammersley, M Signy - Therapeutic advances in chronic …, 2017 - journals.sagepub.com
Atrial fibrillation (AF) is a major cause of ischaemic stroke. The majority of these strokes can
be prevented by treatment with oral anticoagulation therapy. The advent of non-vitamin K …

Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.

JR Dawson, DS Thompson, M Signy, SM Juul… - Heart, 1985 - heart.bmj.com
Dopexamine, a new compound with postjunctional dopamine receptor activating and beta
adrenoceptor agonist properties, was given to 10 patients with chronic heart failure at …

Acute hemodynamic effects of single-dose nicorandil in coronary artery disease

DJ Coltart, M Signy - The American Journal of Cardiology, 1989 - Elsevier
Fifteen patients undergoing routine cardiac catheterization for investigation of chest pain
were given a single dose of 40 mg of nicorandil either sublingually (8 patients) or orally (7 …

Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment

…, V Glover, BL Goodwin, M Sandler, M Signy… - …, 1988 - Springer
Blood pressure and heart rate responses to oral tyramine have been measured in healthy
volunteers before and after administration of the selective monoamine oxidase B inhibitor …

Cardiac pacing in children.

DE Ward, M Signy, P Oldershaw, S Jones… - Archives of Disease in …, 1982 - adc.bmj.com
Twenty patients aged between 12 months and 13 years underwent permanent pacemaker
implantation. The main indication for pacing was post-surgical atrioventricular block. The …

The effect of impaired renal function on the pharmacokinetics of metoprolol after single administration of a 14190 metoprolol OROS system

P Lloyd, VA John, M Signy, SE Smith - American Heart Journal, 1990 - Elsevier
Renal function is known to sometimes have a significant effect on the pharmacokinetics of
drugs or drug metabolites, which are eliminated in appreciable amounts by the kidneys. For …